MedPath

Study on the relationship between pathological tumor regression grade and prognosis of advanced hepatocellular carcinoma after conversion therapy

Not Applicable
Completed
Conditions
hepatocellular carcinoma
Registration Number
ChiCTR2400088877
Lead Sponsor
West China Hospital, Sichuan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

a. Age between 18 and 65 years (including patients aged 18 years) <br>b. Clinical diagnosis is hepatocellular carcinoma (According to the diagnosis and treatment guidelines for primary liver cancer (2022 edition) diagnostic criteria: HBV or HCV infection or cirrhosis caused by any cause, liver nodules = 2 cm in diameter were found, multi-parameter MRI, dynamic enhanced CT, contrast-enhanced ultrasound or hepatocyte specific contrast agent Gd-EOB-DTPA enhanced MRI showed at least 2 typical features of fast forward and fast out of liver cancer; or the presence of intrahepatic nodules> 2 cm in diameter, as long as one of the above four imaging examinations has typical liver cancer characteristics; serum AFP is elevated, especially continuously elevated, and only one of the above four imaging examinations has typical liver cancer characteristics; liver biopsy is definitely diagnosed as HCC) <br>c. For patients with BCLC stage B or C, the first treatment received by the patient was intervention, molecular-targeted drugs, immunotherapy, systemic chemotherapy, etc., and the lesion could be radical surgical resection under imaging evaluation after treatment.<br>d. Normal or downgraded liver function meeting surgical criteria (Child-Pugh A or screening Child-Pugh B liver function, ICG-R15 <14%, ECOG performance score 0-1) <br>e. Can tolerate surgery under general anesthesia

Exclusion Criteria

a. Combined with other malignant tumors<br>b. Patients who did not meet the criteria for conversion surgery after comprehensive treatment, or who did not complete a treatment cycle and withdrew <br>c. The pathological margin after operation did not reach the R0 resection standard<br>d. There are serious functional disorders of heart, brain, lung, kidney and other important organ systems;<br>e. Missing clinicopathological data and uncooperative follow-up.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pathological tumor regression grade;recurrence-free survival;overall survival;postoperative complication;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath